人垂体腺瘤细胞周期中miRNA调控研究进展
本文综述了人垂体腺瘤中微小RNA(miRNA)失调导致细胞周期紊乱的研究进展。垂体腺瘤在颅内肿瘤中患病率约15%,尸检和影像学分析发现其发生率约22.5%,仅0.1%患者发展为垂体癌。目前认为细胞周期破坏在垂体腺瘤发病中起重要作用,miRNA在转录后水平调控基因表达,与细胞周期失调密切相关。
要点
- 垂体腺瘤患病率约15%,在颅内肿瘤中居第三位,仅次于胶质瘤和脑膜瘤。
- 尸检和影像学分析发现垂体腺瘤发生率约22.5%,仅0.1%患者发展为垂体癌。
- miRNA失调与垂体腺瘤细胞周期紊乱密切相关,是近年研究热点。
核心结论
- miRNA失调导致细胞周期紊乱在垂体腺瘤发病中起重要作用,但具体病理机制目前仍知之甚少。
研究设计与样本
- 本文为综述,总结人垂体腺瘤中miRNA失调导致细胞周期破坏的最新研究进展。
主要发现
- 垂体腺瘤是起源于垂体腺细胞的单克隆腺瘤,是蝶鞍区最常见的肿瘤之一。
- 垂体腺瘤患病率约15%,在颅内肿瘤中居第三位,仅次于胶质瘤和脑膜瘤。
- 尸检和影像学分析发现垂体腺瘤发生率约22.5%。
- 大多数垂体腺瘤为良性,仅0.1%患者发展为垂体癌。
- 既往研究已证明垂体腺瘤中miRNA失调与细胞周期失调之间存在强关联。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pituitary adenomas (PAs), single-clone adenomas arising from pituitary gland cells, comprise one of the most frequent tumors found in the sella region. The prevalence of PAs is approximately 15%, third only after gliomas and meningioma among intracranial tumors. Autopsy and radiological analysis found that the incidence of PAs is approximately 22.5%. Most PAs are benign, although a few are malignant. Just 0.1% of patients with PAs develop pituitary carcinoma. However, owing to mass effects and unregulated secretion of pituitary hormones, PAs also lead to serious morbidity. The low rate of diagnosis at onset and the lack of effective treatments for patients with recurrent disease increase the morbidity rates. Therefore, there is an urgent need to ascertain the pathological mechanism of PAs for improved diagnosis and development of specific therapies. At present, the pathogenesis of PAs is poorly understood; however, disruption of the cell cycle is known to play an important role. MicroRNAs are short noncoding RNAs that regulate gene expression at the post-transcriptional level and play a role in regulating genes involved in carcinogenesis or tumor suppression. Previous studies have demonstrated a strong connection between dysregulation of microRNAs and dysregulation of the cell cycle in PAs. In this review, we summarize the recent progress in the study of microRNA dysregulation resulting in disruption of the cell cycle in PAs.
引用
- Zhang T, Yang Z, Gao H, et al. Advancements in the study of miRNA regulation during the cell cycle in human pituitary adenomas. J Neurooncol. 2017. PMID: 28577032. doi:10.1007/s11060-017-2518-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。